A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma

被引:37
作者
Do, Hongdo [1 ,2 ,6 ]
Wong, Nicholas C. [2 ,6 ]
Murone, Carmel [2 ]
John, Thomas [3 ]
Solomon, Benjamin [4 ,5 ]
Mitchell, Paul L. [3 ]
Dobrovic, Alexander [1 ,2 ,4 ,5 ,6 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Pathol, Mol Pathol Res & Dev Lab, Melbourne, Vic 8006, Australia
[2] Austin Hosp, Olivia Newton John Canc & Wellness Ctr, Ludwig Inst Med Res, Translat Genom & Epigen Lab, Heidelberg, Vic 3084, Australia
[3] Austin Hosp, Olivia Newton John Canc & Wellness Ctr, Joint Austin Ludwig Med Oncol Dept, Heidelberg, Vic 3084, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia
[5] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic 8006, Australia
[6] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
基金
英国医学研究理事会;
关键词
MESSENGER-RNA EXPRESSION; CISPLATIN-BASED CHEMOTHERAPY; CLINICAL-RESPONSE; BRCA1; PROMOTER; P53; MUTATION; CANCER; HYPERMETHYLATION; INACTIVATION; ERCC1; TUMOR;
D O I
10.1038/srep04186
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
DNA repair genes that have been inactivated by promoter methylation offer potential therapeutic targets either by targeting the specific repair deficiency, or by synthetic lethal approaches. This study evaluated promoter methylation status for eight selected DNA repair genes (ATM, BRCA1, ERCC1, MGMT, MLH1, NEIL1, RAD23B and XPC) in 56 non-small cell lung cancer (NSCLC) tumours and 11 lung cell lines using the methylation-sensitive high resolution melting (MS-HRM) methodology. Frequent methylation in NEIL1 (42%) and infrequent methylation in ERCC1 (2%) and RAD23B (2%) are reported for the first time in NSCLC. MGMT methylation was detected in 13% of the NSCLCs. Contrary to previous studies, methylation was not detected in ATM, BRCA1, MLH1 and XPC. Data from The Cancer Genome Atlas (TCGA) was consistent with these findings. The study emphasises the importance of using appropriate methodology for accurate assessment of promoter methylation.
引用
收藏
页数:8
相关论文
共 60 条
[1]   A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII [J].
Bandaru, V ;
Sunkara, S ;
Wallace, SS ;
Bond, JP .
DNA REPAIR, 2002, 1 (07) :517-529
[2]   Genome-wide DNA methylation profiling using Infinium® assay [J].
Bibikova, Marina ;
Le, Jennie ;
Barnes, Bret ;
Saedinia-Melnyk, Shadi ;
Zhou, Lixin ;
Shen, Richard ;
Gunderson, Kevin L. .
EPIGENOMICS, 2009, 1 (01) :177-200
[3]   Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients [J].
Boukovinas, Ioannis ;
Papadaki, Chara ;
Mendez, Pedro ;
Taron, Miquel ;
Mavroudis, Dimitris ;
Koutsopoulos, Anastasios ;
Sanchez-Ronco, Maria ;
Javier Sanchez, Jose ;
Trypaki, Maria ;
Staphopoulos, Eustathios ;
Georgoulias, Vassilis ;
Rosell, Rafael ;
Souglakos, John .
PLOS ONE, 2008, 3 (11)
[4]   Optimal primer design using the novel primer design program:: MSPprimer provides accurate methylation analysis of the ATM promoter [J].
Brandes, J. C. ;
Carraway, H. ;
Herman, J. G. .
ONCOGENE, 2007, 26 (42) :6229-6237
[5]   DNA methylation markers and early recurrence in stage I lung cancer [J].
Brock, Malcolm V. ;
Hooker, Craig M. ;
Ota-Machida, Emi ;
Han, Yu ;
Guo, Mingzhou ;
Ames, Stephen ;
Gloeckner, Sabine ;
Piantadosi, Steven ;
Gabrielson, Edward ;
Pridham, Genevieve ;
Pelosky, Kristen ;
Belinsky, Steven A. ;
Yang, Stephen C. ;
Baylin, Stephen B. ;
Herman, James G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1118-1128
[6]   Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma [J].
Chaisaingmongkol, J. ;
Popanda, O. ;
Warta, R. ;
Dyckhoff, G. ;
Herpel, E. ;
Geiselhart, L. ;
Claus, R. ;
Lasitschka, F. ;
Campos, B. ;
Oakes, C. C. ;
Bermejo, J. L. ;
Herold-Mende, C. ;
Plass, C. ;
Schmezer, P. .
ONCOGENE, 2012, 31 (49) :5108-5116
[7]   Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas [J].
Chen, Hua-Yun ;
Shao, Cui-Jie ;
Chen, Fu-Rong ;
Kwan, Aij-Lie ;
Chen, Zhong-Ping .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (08) :1944-1954
[8]   BRCA1 promoter methylation predicts adverse ovarian cancer prognosis [J].
Chiang, Jing Wang ;
Karlan, Beth Y. ;
Cass, Ilana ;
Baldwin, Rae Lynn .
GYNECOLOGIC ONCOLOGY, 2006, 101 (03) :403-410
[9]   Sensitive detection of DNA methylation [J].
Cottrell, SE ;
Laird, PW .
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 :120-130
[10]   DNA repair dysregulation from cancer driver to therapeutic target [J].
Curtin, Nicola J. .
NATURE REVIEWS CANCER, 2012, 12 (12) :801-817